Benoit Beuselinck Selected Research

Ligands

3/2015

Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benoit Beuselinck Research Topics

Disease

78	Renal Cell Carcinoma (Grawitz Tumor) 03/2024 - 08/2010
37	Neoplasms (Cancer) 10/2023 - 08/2010
16	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2012
6	Kidney Neoplasms (Kidney Cancer) 01/2024 - 10/2018
4	Hypoxia (Hypoxemia) 06/2021 - 05/2013
3	Carcinoma (Carcinomatosis) 04/2022 - 02/2011
3	Disease Progression 01/2017 - 06/2013
3	Breast Neoplasms (Breast Cancer) 01/2016 - 07/2010
2	Brain Neoplasms (Brain Tumor) 01/2024 - 12/2021
2	Osteonecrosis (Kienbock's Disease) 01/2023 - 04/2018
2	Heart Failure 10/2022 - 01/2017
2	Myocarditis (Carditis) 10/2022 - 10/2007
2	Fatigue 10/2019 - 07/2010
1	Dermatomyositis (Dermatopolymyositis) 10/2023
1	Systemic Scleroderma (Systemic Sclerosis) 10/2023
1	Rheumatic Diseases (Rheumatism) 10/2023
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Infections 01/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Osteoporosis 01/2023
1	Heart Valve Diseases (Valvular Heart Disease) 10/2022
1	Transient Ischemic Attack 10/2022
1	Stroke (Strokes) 10/2022
1	Acute Coronary Syndrome 10/2022
1	Inflammation (Inflammations) 01/2021
1	Intraoperative Complications 01/2020
1	Urologic Neoplasms (Urological Cancer) 01/2020
1	Hypertension (High Blood Pressure) 10/2019
1	Hypogonadism (Hypergonadotropic Hypogonadism) 06/2019
1	Hypothyroidism 06/2019
1	Colorectal Neoplasms (Colorectal Cancer) 12/2015
1	Lymphatic Metastasis 09/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2014

Drug/Important Bio-Agent (IBA)

22	Sunitinib (Sutent)FDA Link 01/2021 - 05/2011
17	Tyrosine Kinase InhibitorsIBA 01/2023 - 05/2011
13	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 10/2014
11	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
8	NivolumabIBA 03/2024 - 10/2019
7	Biomarkers (Surrogate Marker)IBA 06/2022 - 08/2010
6	MicroRNAs (MicroRNA)IBA 06/2021 - 05/2013
6	pazopanib FDA Link 09/2020 - 05/2014
5	Bevacizumab (Avastin)FDA Link 01/2023 - 01/2012
5	cabozantinibIBA 01/2023 - 01/2019
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 05/2014
4	IpilimumabIBA 03/2024 - 10/2019
3	RNA (Ribonucleic Acid)IBA 10/2023 - 11/2021
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2021 - 05/2011
3	Angiogenesis InhibitorsIBA 07/2020 - 12/2019
2	atezolizumabIBA 01/2023 - 10/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 05/2014
2	Bone Density Conservation AgentsIBA 01/2023 - 04/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 10/2007
2	AntigensIBA 01/2023 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2018
2	C-Reactive ProteinIBA 01/2021 - 07/2014
2	TOR Serine-Threonine KinasesIBA 01/2020 - 05/2014
2	Diphosphonates (Bisphosphonates)IBA 04/2018 - 09/2014
2	Everolimus FDA Link 05/2014 - 06/2013
1	AutoantibodiesIBA 10/2023
1	AntibodiesIBA 10/2023
1	omega-Chloroacetophenone (Mace)IBA 10/2022
1	VaccinesIBA 01/2022
1	ParaffinIBA 12/2021
1	Formaldehyde (Formol)FDA Link 12/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2021
1	Small Untranslated RNAIBA 03/2021
1	Polo-Like Kinase 1IBA 01/2021
1	AcidsIBA 09/2020
1	cyclopropapyrroloindoleIBA 01/2020
1	MTOR InhibitorsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Amylases FDA Link 10/2019
1	Lipase (Acid Lipase)FDA Link 10/2019
1	Alanine Transaminase (SGPT)IBA 10/2019
1	Testosterone (Sustanon)FDA Link 06/2019
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 06/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019
1	Denosumab FDA Link 04/2018
1	B7-H1 AntigenIBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 12/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	Hormones (Hormone)IBA 05/2015
1	Estrogen ReceptorsIBA 05/2015
1	LigandsIBA 03/2015
1	temsirolimus FDA Link 05/2014
1	Axitinib (AG 013736)IBA 05/2014
1	thiamine triphosphorate (TTP)IBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 05/2013

Therapy/Procedure

37	Therapeutics 01/2024 - 10/2007
10	Nephrectomy 10/2023 - 01/2012
3	Immunotherapy 10/2023 - 01/2022
3	Metastasectomy 06/2022 - 10/2018
3	Drug Tapering 09/2020 - 10/2014
2	Radiotherapy 01/2023 - 01/2017
1	Oral Surgery (Maxillofacial Surgery) 01/2023
1	Minimally Invasive Surgical Procedures 01/2021
1	Time-to-Treatment 01/2020
1	Duration of Therapy 01/2020
1	Thrombectomy 01/2020
1	Precision Medicine 12/2015